Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma

by Tian-mei Zeng, Tian-mei Zeng, Yu-fei Pan, Zhen-gang Yuan, Dong-sheng Chen, Yun-jie Song, Yong Gao, Yong Gao
Published 2022-09-01

Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre pha...

by Tian‐mei Zeng, Tian‐yi Jiang, Guang Yang, Zhuo Cheng, Cheng Lou, Wei Wei, Chen‐jie Tao, Shouzi Hu, Hui Wang, Xiao‐wen Cui, Ye‐xiong Tan, Li‐wei Dong, Hong‐yang Wang, Zhen‐gang Yuan
Published 2024-05-01

Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer

by Tian-mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-jie Tao, Xi-yun Chen, Qin Han, Zhuo Cheng, Pei-pei Shang, Yu-long Dong, He-ming Xu, Lie-ping Guo, Dong-sheng Chen, Yun-jie Song, Chuang Qi, Wang-long Deng, Zhen-gang Yuan
Published 2023-03-01